HomeXTLB • NASDAQ
add
X T L Biopharmaceuticals Ltd
Previous close
$2.60
Day range
$2.46 - $2.59
Year range
$0.75 - $4.99
Market cap
13.72M USD
Avg Volume
1.57M
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 151.00K | -25.98% |
Net income | -215.00K | 73.81% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -150.75K | 26.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.21M | -49.72% |
Total assets | 2.66M | -45.62% |
Total liabilities | 162.00K | 5.88% |
Total equity | 2.50M | — |
Shares outstanding | 544.91M | — |
Price to book | ∞ | — |
Return on assets | -13.62% | — |
Return on capital | -14.47% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -215.00K | 73.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website